Longevity in the News: Coenzyme Q10 shown to reverse memory deficits

January 1, 1970

New antibody reduces amyloid plaques associated with Alzheimer’s disease

A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer’s disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.

Read More >>

Stem cells could be key to slowing aging process

A team of researchers at the University of Auckland, New Zealand found that women’s stem cells are more potent than men’s, which may explain why women live longer.

Read More >>

Coenzyme Q10 shown to reverse memory deficits

Q10 reverses aging-induced memory impairment. Reduces ATP production, decrease in mitophagy-related proteins (PINK, Parkin, and P62 levels and LC3II/I ratio), excessive generation of reactive oxygen species and lipid peroxidation, and apoptosis in the hippocampus. 

Read More >>

Detecting infections faster with CRISPR-Cas

Wageningen University & Research (WUR) has received a grant of 150,000 euros from the European Research Council (ERC), together with spinoff Scope Biosciences, to further research and enhance their diagnostic technology ScopeDx.

Read More >>

Pretzel Therapeutics launches with $72.5m Series A to pioneer mitochondrial therapies for longevity

Pretzel Therapeutics, a biotech company focused on harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched yesterday with a $72.5 million Series A financing.

Read More >>

Scientists find a drug that may reduce muscle aging

Scientists have found that a well-known drug can delay the progression of age-related muscle weakness by suppressing mTORC1. 

Read More >>